Regarding the Medical Fee Revision – PT-OT

This time"Regarding the Medical Fee Revision"M&A Medical's perspective on this news goes beyond merely reporting a system change, instead suggestinga structural turning point in the management of medical institutions in Japan.The "tightening of facility standards" and "review of nursing staff allocation" strongly imply that it may become difficult for smaller medical institutions to sustain themselves under traditional management models. This will accelerate the transition from an era where individual clinics and hospitals survive independently to one where groups with more efficient and robust management foundations are required.

In the context of medical M&A and business succession, this revisionreaffirms the importance of M&A as a "survival strategy."Specifically, the "economies of scale" mentioned, such as maintaining facility standards and distributing the burden of capital investment, can be an effective option for business owners facing succession issues, especially when independent succession is difficult. Even if a successor cannot be found, joining an existing medical group offers a path to continue contributing to regional healthcare while mitigating management risks.

For medical institution managers and those facing succession challenges, a key takeaway isthe perspective of viewing the medical fee revision as an "opportunity to strengthen management."It is essential not only to respond to immediate revisions but also to evaluate the "sustainability" of one's institution from a medium-to-long-term perspective and, if necessary, actively consider M&A or group formation. The utilization of tax schemes, particularly "transition to specified medical corporations or social medical corporations," is a crucial factor in enhancing business continuity after succession. It is vital to objectively assess the "strengths" and "weaknesses" of one's institution within the current management environment and to envision the optimal future with the help of experts.